/

/

Master Trial Index (All Years)

/

LEVOECMO

Category

Neurocritical Care & Cardiac Arrest

Full Summary

https://app.notion.com/p/3ab1a8cd5af1818e8364f44ee9df903e

Journal

JAMA

Takeaway

Levosimendan did not facilitate VA-ECMO weaning or improve survival in cardiogenic shock.

Verdict

Null / Equivalence

Year

2025

myICUnotes © 2026 by Dr Abhijeet Anand is licensed under CC BY-NC-SA 4.0. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/